MondegarAI
MIC Capital Management UK LLP

Q2 2025 · 13F-HR

MIC Capital Management UK LLPholdings as filed

Filed 2025-08-14 · accession 0001085146-25-005259

$509.3M
Reported value
13
Positions
2025-06-30
Period end
View analyzed profile →PRO

The Brief · MIC Capital Management UK LLP · Q2 2025

AI · grounded in 13F

MIC Capital Management UK LLP established a new position in HAYW valued at $145.6M. The fund also initiated stakes in METSERA INC for $129.1M and RXRX for $48.8M. Additional new positions include CPNG at $42.3M, QSR at $25.6M, and GRAB at $25.2M. Total assets under management stand at $509.3M across 13 positions.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
421298100HAYWHAYWARD HLDGS INC$145.6M28.6%10,548,539CommonSOLE
59267L107METSERA INC$129.1M25.4%4,539,540CommonSOLE
75629V104RXRXRECURSION PHARMACEUTICALS IN$48.8M9.58%9,644,032CommonSOLE
22266T109CPNGCOUPANG INC$42.3M8.31%1,412,946CommonSOLE
76131D103QSRRESTAURANT BRANDS INTL INC$25.6M5.03%386,203CommonSOLE
G4124C109GRABGRAB HOLDINGS LIMITED$25.1M4.94%5,000,000CommonSOLE
30303M102METAMETA PLATFORMS INC$24.6M4.83%33,300CommonSOLE
M7S64H106MNDYMONDAY COM LTD$20.8M4.08%66,000CommonSOLE
76155X100RVMDREVOLUTION MEDICINES INC$18.7M3.67%508,569CommonSOLE
01609W102BABAALIBABA GROUP HLDG LTD$17.0M3.34%150,000CommonSOLE
03945R102ACHRARCHER AVIATION INC$7.6M1.49%700,000CommonSOLE
640979100NMRANEUMORA THERAPEUTICS INC.$3.3M0.64%4,460,700CommonSOLE
55083R203LYELLYELL IMMUNOPHARMA INC$769,3280.15%87,028CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.